Xbrane Biopharma AB (publ) (STO:XBRANE)
11.00
+1.00 (10.00%)
Apr 30, 2026, 12:59 PM CET
Xbrane Biopharma AB Revenue
In the year 2025, Xbrane Biopharma AB had annual revenue of 152.35M SEK with 2.87% growth. Xbrane Biopharma AB had revenue of 9.09M in the quarter ending December 31, 2025.
Revenue
152.35M
Revenue Growth
+2.87%
P/S Ratio
1.49
Revenue / Employee
5.25M
Employees
26
Market Cap
226.66M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 152.35M | 4.26M | 2.87% |
| Dec 31, 2024 | 148.10M | -90.63M | -37.96% |
| Dec 31, 2023 | 238.73M | 181.11M | 314.33% |
| Dec 31, 2022 | 57.62M | 46.91M | 438.03% |
| Dec 31, 2021 | 10.71M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bio-Works Technologies AB | 63.11M |
| Elicera Therapeutics AB | 10.64M |
| NextCell Pharma AB | 9.83M |
| Xintela AB | 2.28M |
| Alligator Bioscience AB | 839.00K |
| Diamyd Medical AB | 362.00K |
| Mendus AB | -1.44M |
Xbrane Biopharma AB News
- 2 months ago - Xbrane Biopharma AB Earnings Call Transcript: Q4 2025 - Transcripts
- 6 months ago - Xbrane Biopharma AB Earnings Call Transcript: Q3 2025 - Transcripts
- 7 months ago - Xbrane Biopharma AB Transcript: Investing in Life Science 2025 - Transcripts
- 8 months ago - Xbrane Biopharma AB Earnings Call Transcript: Q2 2025 - Transcripts
- 1 year ago - Xbrane Biopharma AB Earnings Call Transcript: Q1 2025 - Transcripts
- 1 year ago - Xbrane Biopharma AB Earnings Call Transcript: Q4 2024 - Transcripts
- 1 year ago - Xbrane Biopharma AB Earnings Call Transcript: Q3 2024 - Transcripts
- 1 year ago - Xbrane Biopharma AB Earnings Call Transcript: Q2 2024 - Transcripts